Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 17Head & Neck 4Gynecologic 3Genitourinary 3Tumor-Agnostic 2Thoracic 2Other 2Endocrine 2Sarcoma 1NET 1Breast 1

Conditions

Invasive Breast Carcinoma 1

Interventions

Cyclophosphamide 423Trastuzumab 414Paclitaxel 375Docetaxel 314Capecitabine 266Letrozole 262Carboplatin 257Doxorubicin 213Tamoxifen 184Fulvestrant 176Epirubicin 176Radiotherapy 171Anastrozole 164pembrolizumab 152pertuzumab 147Surveys and Questionnaires 146Exercise 142exemestane 128Vinorelbine 127palbociclib 124Bevacizumab 123Magnetic Resonance Spectroscopy 120Blood Specimen Collection 120Drug Therapy 106Albumin-Bound Paclitaxel 105Gemcitabine 99130-nm albumin-bound paclitaxel 98pyrotinib 92eribulin 90Biopsy 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Robotic Surgical Procedures × Breast × Clear all
NCT06738654 2026-06-02

单孔机器人-SPR

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Phase NA Recruiting
64 enrolled
Breast

Invasive Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡